A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability

Blood

Volumn 97, Issue 5, 2001, Pages 1321-1329

  Clauss, Matthias ^a   Sunderkötter, Cord ^b   Sveinbjörnsson, Baldur ^b   Hippenstiel, Stefan ^b   Willuweit, Antje ^b   Marino, Michael ^b   Haas, Elvira ^b   Seljelid, Rolf ^b   Scheurich, Peter ^b   Suttorp, Norbert ^b   Grell, Matthias ^b   Risau, Werner ^b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CYTOFLUOROMETRY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035282925     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1321     Document Type: Article

References (64)

1. Mechanisms of angiogenesis
2. Vascular permeability factor
3. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation
4. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies
5. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid
6. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: Implications for acquired immunodeficiency syndrome-associated vasculopathy
7. Expression of vascular endothelial growth factor by human eosinophils: Up-regulation by granulocyte macrophage colony-stimulating factor and interleukin-5
8. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
9. Transvascular drug delivery in solid tumors
10. Recombinant human tumor necrosis factor-α; thrombus formation is a cause of antitumor activity
11. The antitumor function of tumor necrosis factor (TNF): Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity
12. Complete response of melanoma-in-transit metastasis after isolated limb perfusion with tumor necrosis factor alpha and melphalan without massive tumor necrosis: A clinical and histopathological study of the delayed-type reaction pattern
13. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level
14. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
15. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice
16. Tumour regression after treatment with aminated beta-1,3-D-polyglucose is initiated by circulatory failure
17. Detection of membrane-bound tumor necrosis factor (TNF): An analysis of TNF-specific reagents
18. Characterization of different soluble TNF receptor (TNFR80) derivatives: Positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacity
19. The vascular endothelial growth factor receptor flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
20. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease
21. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells
22. Angiotensin AT2 receptor degradation is prevented by ligand occupation
23. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
24. Role of phosphodiesterases in the regulation of endothelial permeability in vitro
25. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha
26. Tumor necrosis factor/cachetin-induced intravascular fibrin formation in meth A fibrosarcoma
27. Continuous autotropic signaling by membrane-expressed tumor necrosis factor
28. Development of resistance to tumour necrosis factor (TNF alpha) in KYM-1 cells involves both TNF receptors
29. Tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors
30. VEGF induces hyperpermeability by a direct action on endothelial cells
31. Characterization of tumor necrosis factor-deficient mice
32. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
33. Mechanism of the tumour-necrosis factor α-mediated induction of endothelial tissue factor
34. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells
35. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells
36. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO
37. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway
38. Nitric oxida synthase modulates angiogenesis in response to tissue ischemia
39. VEGF induces NO-dependent hyperpermeability in coronary venules
40. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by II-1 and INF-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody
41. Vascular endothelial growth factor induces endothelial fenestration in vitro
42. Tumor necrosis factor-alpha augments arterial transendothelial albumin flux in vitro
43. Vascular endothelial growth factor and microvascular permeability
44. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels
45. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo
46. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
47. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability
48. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
49. Angiopoietin-1 protects the adult vasculature against plasma leakage
50. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium
51. Nitric oxide modulation of focal adhesions in endothelial cells
52. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
53. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
54. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
55. Tumour necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells
56. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
57. Tumour necrosis factor-alpha gone expression and production in human umbilical arterial endothelial cells
58. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops
59. Detection and localization of tumor necrosis factor in human atheroma
60. Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species
61. The adhesion molecule and cytokine profile of multiple sclerosis lesions
62. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin
63. Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha
64. Constitutive expression of phVEGF 165 after intramuscular gone transfer promotes collateral vessel development in patients with critical limb ischemia